Status:
UNKNOWN
Genetic Testing in Upper Tract Urothelial Carcinoma (UTUC): the Epicheck Study
Lead Sponsor:
Fundacio Puigvert
Collaborating Sponsors:
Nucleix Ltd.
Conditions:
Urologic Cancer
Urologic Neoplasms
Eligibility:
All Genders
18+ years
Brief Summary
Background: Upper tract urothelial carcinoma (UTUC) is a rare tumor associated with bladder cancer in up to 50% of cases. Its incidence is rising due to improved detection and bladder cancer survival...
Eligibility Criteria
Inclusion
- Patients suspected for primary or recurrent upper tract urothelial cancer requiring ureteroscopy
Exclusion
- Metastatic disease with patient unfit for ureteroscopy
- Positive cystoscopy (concomitant presence of bladder cancer)
- Macroscopic hematuria not self-limiting requiring upfront nephroureterectomy
Key Trial Info
Start Date :
February 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04702347
Start Date
February 1 2019
End Date
February 28 2021
Last Update
January 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fundacio Puigvert
Barcelona, Spain, 08025